Biogen Inc. (BIIB) Gets Upgraded by UBS on Upcoming Pipeline Catalysts
Biogen Inc. (NASDAQ:BIIB) is one of the best stem cell therapy stocks to buy. On April 22, Biogen Inc.…
This pharmaceutical stock is cheap relative to peers. UBS thinks it’s due for a bounce
Biogen is trading at a discount and could soon rise thanks to a combination of catalysts, making now…
Novartis, Roche could be most at risk
Medications are stored on shelves at a pharmacy on May 12, 2025 in Los Angeles, California. Eric Thayer…